How Huawei Could Profit From Successful Vaccine
Mail Today|August 05, 2020
We're offering this story for free to read so that you can stay updated on the COVID-19 outbreak
How Huawei Could Profit From Successful Vaccine
Two scientists behind Oxford University's coronavirus vaccine could pocket a hefty sum of money if the jab proves successful, it emerged on Tuesday.

Several private investors, including the controversial Chinese firm Huawei, are also poised to profit if the vaccine — called AZD1222 — goes to market.


You can read up to 3 premium stories before you subscribe to Magzter GOLD

Log in, if you are already a subscriber


Get unlimited access to thousands of curated premium stories, newspapers and 5,000+ magazines


August 05, 2020